Berenberg Bank Reiterates Buy Rating for Genus (LON:GNS)

Genus (LON:GNS)‘s stock had its “buy” rating reaffirmed by equities researchers at Berenberg Bank in a note issued to investors on Wednesday,London Stock Exchange reports. They presently have a GBX 3,350 price objective on the stock. Berenberg Bank’s price objective would indicate a potential upside of 33.34% from the stock’s previous close.

Several other research analysts have also recently weighed in on the stock. Deutsche Bank Aktiengesellschaft upped their price target on shares of Genus from GBX 3,100 to GBX 3,300 and gave the company a “buy” rating in a report on Friday, January 16th. Shore Capital Group reaffirmed a “buy” rating and issued a GBX 3,000 price objective on shares of Genus in a research report on Friday, January 16th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Genus presently has an average rating of “Buy” and an average price target of GBX 3,216.67.

Genus Trading Up 2.5%

LON:GNS opened at GBX 2,512.44 on Wednesday. The company has a debt-to-equity ratio of 55.10, a current ratio of 2.25 and a quick ratio of 1.08. The business’s 50-day simple moving average is GBX 2,840.78 and its 200-day simple moving average is GBX 2,644.63. Genus has a fifty-two week low of GBX 1,548 and a fifty-two week high of GBX 3,220. The stock has a market capitalization of £1.67 billion, a PE ratio of 86.94, a price-to-earnings-growth ratio of 2.87 and a beta of 0.85.

Genus (LON:GNS) last posted its earnings results on Thursday, February 26th. The company reported GBX 60.80 earnings per share (EPS) for the quarter. Genus had a return on equity of 9.70% and a net margin of 7.07%. Sell-side analysts expect that Genus will post 70.9644323 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Celia Baxter purchased 1,728 shares of Genus stock in a transaction on Friday, February 27th. The stock was purchased at an average price of GBX 2,893 per share, with a total value of £49,991.04. 0.70% of the stock is currently owned by company insiders.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.